SCHEMBL2240346

SCHEMBL2240346

O=C(O)[C@H](CSCc1ccccc1)NCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACE P12821 4/20 0.57
PPARA Q07869 6/20 0.53
PPARG P37231 4/20 0.53
PPARD Q03181 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11347298 0.92 PPARA (0.61) ACEPPARAPPARG
SCHEMBL3963130 0.89 ACE (0.58) ACEPPARAPPARGPPARD
SCHEMBL3963125 0.89 ACE (0.58) ACEPPARAPPARGPPARD
Hydrochloric Acid SCHEMBL18260619 0.87 ACE (0.57) ACEPPARAPPARGPPARD
SCHEMBL14405000 0.86 ACE (0.59) ACEPPARAPPARGPPARD
SCHEMBL9320401 0.83 ANPEP (0.48)
SCHEMBL2238427 0.83 METAP2 (0.53) ACEPPARAPPARG
SCHEMBL8997911 0.82 ACE (0.62) ACEPPARAPPARGPPARD
SCHEMBL5217215 0.82 ACE (0.62) ACEPPARAPPARGPPARD
SCHEMBL8997921 0.82 ACE (0.62) ACEPPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200231532-A1 Supported Metal Catalysts JOHNSON MATTHEY PLC (GB) 2020-07-23 US claimed
US-20180099923-A1 Supported Metal Catalysts JOHNSON MATTHEY PLC (GB) 2018-04-12 US claimed
EP-2536500-B1 SUPPORTED METAL CATALYSTS JOHNSON MATTHEY PLC (GB) 2016-12-07 EP claimed
EP-2536500-A1 SUPPORTED METAL CATALYSTS Johnson Matthey PLC (GB) 2012-12-26 EP claimed
CN-102834174-A Supported metal catalysts JOHNSON MATTHEY PLC 2012-12-19 CN claimed
WO-2011101679-A1 SUPPORTED METAL CATALYSTS JOHNSON MATTHEY PLC (GB) 2011-08-25 WO claimed
US-20200231532-A1 Supported Metal Catalysts JOHNSON MATTHEY PLC (GB) 2020-07-23 US disclosed
US-20180099923-A1 Supported Metal Catalysts JOHNSON MATTHEY PLC (GB) 2018-04-12 US disclosed
EP-2536500-B1 SUPPORTED METAL CATALYSTS JOHNSON MATTHEY PLC (GB) 2016-12-07 EP disclosed
EP-2536500-A1 SUPPORTED METAL CATALYSTS Johnson Matthey PLC (GB) 2012-12-26 EP disclosed
CN-102834174-A Supported metal catalysts JOHNSON MATTHEY PLC 2012-12-19 CN disclosed
WO-2011101679-A1 SUPPORTED METAL CATALYSTS JOHNSON MATTHEY PLC (GB) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200231532-A1 Supported Metal Catalysts SOD1, HNMT, SOD3 ACE 914/4885PPARA 3524/4885PPARG 4398/4885
US-20180099923-A1 Supported Metal Catalysts SOD1, HNMT, SOD3 ACE 914/4885PPARA 3524/4885PPARG 4398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.